BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37725101)

  • 1. Large extracellular vesicles derived from human regulatory macrophages (L-EV
    Albrecht M; Hummitzsch L; Rusch R; Eimer C; Rusch M; Heß K; Steinfath M; Cremer J; Fändrich F; Berndt R; Zitta K
    J Mol Med (Berl); 2023 Nov; 101(11):1437-1448. PubMed ID: 37725101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?
    Albrecht M; Hummitzsch L; Rusch R; Heß K; Steinfath M; Cremer J; Lichte F; Fändrich F; Berndt R; Zitta K
    J Transl Med; 2023 Jan; 21(1):61. PubMed ID: 36717876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28-Stimulated T Cell IFN-γ and TNF-α Production.
    Calianese D; Kreiss T; Kasikara C; Davra V; Lahey KC; Gadiyar V; Geng K; Singh S; Honnen W; Jaijyan DK; Reichman C; Siekierka J; Gennaro ML; Kotenko SV; Ucker DS; Brekken RA; Pinter A; Birge RB; Choudhary A
    J Immunol; 2021 Jul; 207(2):436-448. PubMed ID: 34215655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human fetal retinal pigment epithelium suppresses the activation of CD4(+) and CD8(+) T-cells.
    Farrokh-Siar L; Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):934-9. PubMed ID: 10541905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
    Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
    Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation.
    Levine BL; Cotte J; Small CC; Carroll RG; Riley JL; Bernstein WB; Van Epps DE; Hardwick RA; June CH
    J Hematother; 1998 Oct; 7(5):437-48. PubMed ID: 9829318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation.
    Li Y; Kurlander RJ
    J Transl Med; 2010 Oct; 8():104. PubMed ID: 20977748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
    Carabasi MH; DiSanto JP; Yang SY; Dupont B
    Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
    Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
    Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.
    Li Q; Yu B; Grover AC; Zeng X; Chang AE
    J Immunother; 2002; 25(4):304-13. PubMed ID: 12142553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation.
    Meyer T; Oberg HH; Peters C; Martens I; Adam-Klages S; Kabelitz D; Wesch D
    J Leukoc Biol; 2012 Oct; 92(4):765-74. PubMed ID: 22750548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of differentiated CD3
    Worel N; Grabmeier-Pfistershammer K; Kratzer B; Schlager M; Tanzmann A; Rottal A; Körmöczi U; Porpaczy E; Staber PB; Skrabs C; Herkner H; Gudipati V; Huppa JB; Salzer B; Lehner M; Saxenhuber N; Friedberg E; Wohlfarth P; Hopfinger G; Rabitsch W; Simonitsch-Klupp I; Jäger U; Pickl WF
    Front Immunol; 2022; 13():1004703. PubMed ID: 36700229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
    Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
    J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ and CD8+ CD28(null) T Cells Are Cytotoxic to Autologous Muscle Cells in Patients With Polymyositis.
    Pandya JM; Venalis P; Al-Khalili L; Shahadat Hossain M; Stache V; Lundberg IE; Malmström V; Fasth AE
    Arthritis Rheumatol; 2016 Aug; 68(8):2016-26. PubMed ID: 26895511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cell isolation method on the optimization of CD4+ T cell expansion using anti-CD3/CD28 coated beads.
    Onlamoon N; Boonchan M; Unpol P; Khunweeraphong N; Sukapirom K; Ammaranond P; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2013 Jun; 31(2):99-105. PubMed ID: 23859408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Novel Selenopolysaccharide Isolated from
    Roszczyk A; Zych M; Zielniok K; Krata N; Turło J; Klimaszewska M; Zagożdżon R; Kaleta B
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.